Home » Topics » BioWorld Science

BioWorld Science
RSS

Positive preclinical data presented for Cocrystal Pharma's CC-42344

Sep. 4, 2019

Pfizer synthesizes new KRAS inhibitors

Sep. 4, 2019

Phase III AMPLIFY study of phosphate absorption inhibitor tenapanor meets primary endpoint

Sep. 4, 2019

Discovery of a first-in-class dual adenosine A2A/A2B receptor antagonist

Sep. 4, 2019

Machine learning from adversity speeds compound development

Sep. 4, 2019

Biogen explores non-covalent activation of NRF2 for neurodegenerative and other disorders

Sep. 4, 2019

Fulacimstat does not improve standard of care treatment in CHIARA MIA 2 study

Sep. 4, 2019

BMS-986235 shows efficacy in preclinical models of heart failure

Sep. 4, 2019

TAS-4464 demonstrates potent antitumor activity in hematologic and solid tumor models

Sep. 4, 2019

Positive phase II data presented for CTP-543 in patients with alopecia areata

Sep. 4, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...